These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20493180)

  • 1. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum.
    Schulte J; Struck J; Bergmann A; Köhrle J
    Clin Chim Acta; 2010 Sep; 411(17-18):1258-63. PubMed ID: 20493180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis.
    Schulte J; Struck J; Köhrle J; Müller B
    Shock; 2011 May; 35(5):460-5. PubMed ID: 21283059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department.
    Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress.
    Iuchi Y; Okada F; Tsunoda S; Kibe N; Shirasawa N; Ikawa M; Okabe M; Ikeda Y; Fujii J
    Biochem J; 2009 Apr; 419(1):149-58. PubMed ID: 19105792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an immunoluminometric assay (ILMA) for fetuin-A-glycoprotein.
    Bäumer A; Schmidt-Gayk H; Aulmann M; Kim TS
    J Immunoassay Immunochem; 2010; 31(1):10-23. PubMed ID: 20391014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
    Abbasi A; Corpeleijn E; Postmus D; Gansevoort RT; de Jong PE; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Peelen LM; Beulens JW; Stolk RP; Navis G; Bakker SJ
    J Am Heart Assoc; 2012 Oct; 1(5):e002956. PubMed ID: 23316297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum.
    Hollenbach B; Morgenthaler NG; Struck J; Alonso C; Bergmann A; Köhrle J; Schomburg L
    J Trace Elem Med Biol; 2008; 22(1):24-32. PubMed ID: 18319137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).
    Gerrits EG; Alkhalaf A; Landman GW; van Hateren KJ; Groenier KH; Struck J; Schulte J; Gans RO; Bakker SJ; Kleefstra N; Bilo HJ
    PLoS One; 2014; 9(2):e89719. PubMed ID: 24586984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.
    Morgenthaler NG; Müller B; Struck J; Bergmann A; Redl H; Christ-Crain M
    Shock; 2007 Aug; 28(2):219-26. PubMed ID: 17515850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    Abbasi A; Corpeleijn E; Gansevoort RT; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Stolk RP; Navis G; Bakker SJ
    Diabetologia; 2014 Sep; 57(9):1842-9. PubMed ID: 24893865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the membrane-bound form of peroxiredoxin 4 in acrosome formation during spermiogenesis of rats.
    Sasagawa I; Matsuki S; Suzuki Y; Iuchi Y; Tohya K; Kimura M; Nakada T; Fujii J
    Eur J Biochem; 2001 May; 268(10):3053-61. PubMed ID: 11358524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis.
    Book M; Chen Q; Lehmann LE; Klaschik S; Weber S; Schewe JC; Luepertz M; Hoeft A; Stuber F
    Crit Care; 2007; 11(1):R19. PubMed ID: 17302973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for the selective measurement of amino-terminal variants of procalcitonin.
    Struck J; Strebelow M; Tietz S; Alonso C; Morgenthaler NG; van der Hoeven JG; Pickkers P; Bergmann A
    Clin Chem; 2009 Sep; 55(9):1672-9. PubMed ID: 19574469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the peroxidase activity and inactivation of human peroxiredoxin 4.
    Wang X; Wang L; Wang X; Sun F; Wang CC
    Biochem J; 2012 Jan; 441(1):113-8. PubMed ID: 21916849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
    Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
    Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.